Donor Lymphocyte Infusion for Relapsed Hematological Malignancies after Unrelated Allogeneic Bone Marrow Transplantation Facilitated by the Japan Marrow Donor Program-Reference-Cited by-同舟云学术

Donor Lymphocyte Infusion for Relapsed Hematological Malignancies after Unrelated Allogeneic Bone Marrow Transplantation Facilitated by the Japan Marrow Donor Program

Published:2017-06 Issue:6 Volume:23 Page:938-944
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Miyamoto Toshihiro^ORCID,Fukuda Takahiro,Nakashima Marie,Henzan Tomoko,Kusakabe Shinsuke,Kobayashi Naoki,Sugita Junichi,Mori Takeshi,Kurokawa Mineo,Mori Shin-ichiro

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference47 articles.

1. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients;Kolb;Blood,1990

2. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation;Collins;J Clin Oncol,1997

3. Donor Lymphocyte Infusion in the Treatment of First Hematological Relapse After Allogeneic Stem-Cell Transplantation in Adults With Acute Myeloid Leukemia: A Retrospective Risk Factors Analysis and Comparison With Other Strategies by the EBMT Acute Leukemia Working Party

4. Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia;Porter;N Engl J Med,1994

5. Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation: efficacy and toxicity of a defined T-cell dose;Drobyski;Blood,1993

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modified Prophylactic Donor Lymphocyte Infusion (DLI) in an Adult T Cell Lymphoma/Leukemia (ATLL) Patient—Modality of Relapse Prevention;Diseases;2024-09-11

2. A case of posttransplant isolated extramedullary relapse of acute lymphoblastic leukemia achieving durable treatment-free remission with blinatumomab and donor lymphocyte infusion;International Journal of Hematology;2024-08-30

3. FLT‐3 mutation maybe an inferior predictor of daratumumab therapy in acute myeloid leukemia patients relapsed after allogeneic stem cell transplantation;International Journal of Laboratory Hematology;2024-04-10

4. The graft versus leukemia effect: donor lymphocyte infusions and cellular therapy;Frontiers in Immunology;2024-03-15

5. Donor Lymphocyte Infusion for Relapsed Acute Leukemia or Myelodysplastic Syndrome after Hematopoietic Stem Cell Transplantation: A Single-Institute Retrospective Analysis;Internal Medicine;2024-01-15